1st Detect Awarded U.S. Patent for Improving Mass Spectrometer Performance

1st Detect Awarded U.S. Patent for Improving Mass Spectrometer Performance

AUSTIN, Texas, June 12, 2014 (GLOBE NEWSWIRE) -- 1^st Detect Corporation, a
subsidiary of Astrotech Corporation (Nasdaq:ASTC), announced today that the
United States Patent Office ("USPTO") has allowed the issuance of a key patent
for controlling the company's unique ion trap used for chemical analysis and
detection. "We are extremely pleased that the USPTO has allowed this patent.
This patent further strengthens our intellectual property portfolio as it
allows 1^st Detect to maintain the stable performance of large laboratory
instruments, yet keep the size and weight of a small, transportable
instrument." said Thomas B Pickens III, Chairman and CEO of 1^st Detect. "The
patent clearly validates our technology, while both demonstrating and
protecting the progress we have made in the development of the 1^st Detect
mass spectrometer."

U.S. Patent No. 8,754,361, entitled, 'Systems and Methods for Adjusting a Mass
Spectrometer Output,' represents a key technological advantage for 1^st Detect
to produce the stable output required of portable small mass spectrometers
without increasing the cost or complexity of the instrument.

"The technology protected by this patent demonstrates our ability to offer
small, affordable mass spectrometers that produce the highest quality, most
stable output, a critical requirement for deploying mass spectrometry outside
of the traditional laboratory setting." added David Rafferty, the inventor of
the novel technology and President and CTO of 1^st Detect.

1^st Detect Corporation has developed an instrument that revolutionizes the
chemical detection and analysis market by delivering lab performance mass
spectrometry in a small, affordable and easily portable package. The 1^st
Detect mass spectrometer is capable of detecting a wide variety of chemicals
including residues and vapors from explosives, chemical warfare agents, toxic
chemicals, food and beverage contaminants, and pollutants. These abilities
make itan ideal tool for a variety of applications in the research, security,
industrial, process flow and healthcare markets.

About 1^st Detect Corporation

1^stDetect Corporation was formed by Astrotech Corporation (Nasdaq:ASTC) to
develop and commercialize miniature mass spectrometer technology first
developed under an agreement with NASA for use on the International Space
Station. 1^st Detect offers a breakthrough miniaturized mass spectrometer that
fills an unmet need by being highly accurate, rapid, lightweight, and
cost-effective. For more information on 1^st Detect Corporation, please
visitwww.1stDetect.com.

About Astrotech Corporation

Astrotech is one of the first space commerce companies and remains a strong
entrepreneurial force in the aerospace industry. We are leaders in
identifying, developing and marketing space technology for commercial use. Our
Astrotech Space Operations business unit serves our government and commercial
satellite and spacecraft customers with pre-launch services on the eastern and
western range. 1^st Detect Corporation has developed a breakthrough miniature
mass spectrometer, while Astrogenetix, Inc. is a biotechnology company
utilizing microgravity as a research platform for drug discovery and
development.

This press release contains forward-looking statements that are made pursuant
to the Safe Harbor provisions of the Private Securities Litigation Reform Act
of 1995. Such forward-looking statements are subject to risks, trends, and
uncertainties that could cause actual results to be materially different from
the forward-looking statement. These factors include, but are not limited to,
continued government support and funding for key space programs, product
performance and market acceptance of products and services, as well as other
risk factors and business considerations described in the Company's Securities
and Exchange Commission filings including the annual report on Form 10-K. Any
forward-looking statements in this document should be evaluated in light of
these important risk factors. The Company assumes no obligation to update
these forward-looking statements.

CONTACT: FOR MORE INFORMATION:
        
         Joshua Elbaum
         VP, Marketing
         +1 (512) 485-9530

company logo
 
Press spacebar to pause and continue. Press esc to stop.